EUVIMEDEUVIMED entdecken
Crossref

CILF: CRISPR/Cas9 based integration of large DNA fragments in Saccharomyces cerevisiae

Shijie Xu, Jie Meng, Qi Zhang, Baisong Tong, Zihe Liu, Jinyu Fu, Shuobo Shi

Biotechnology and Bioengineering · 2024

DOI: 10.1002/bit.28830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2024. Verfasst von Shijie Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Te…. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, CRISPR-Cas Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project, Key-Area Research and Development Program of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome integration technology has markedly expedited the construction of cell factories. However, its application is currently limited by the inefficient integration of large DNA fragments. Here, we report a CRISPR/Cas9 based integration of large DNA fragments (CILF) method to efficiently integrate large DNA fragments in Saccharomyces cerevisiae . In this approach, a fusion protein, Cas9‐Brex27‐FadR, was employed for the targeted delivery of donor plasmid to double‐strand breaks (DSBs), while simultaneously recruiting Rad51 to enhance the efficiency of homologous recombination (HR). Our findings demonstrate that this method can achieve an integration efficiency of 98% for 10 kb DNA fragments and nearly 80% for 40 kb DNA fragments at a single site, using donor plasmids with 1000 bp homology arms (HAs) and 12 FadR binding sites (BSs). The CILF technique significantly enriches the synthetic biology toolbox of S. cerevisiae , offering significant potential to propel advancements in both synthetic biology and metabolic engineering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Saccharomyces cerevisiaeCRISPR-Cas SystemsPlasmidsDNA, FungalHomologous Recombination

Stichwörter der Autor:innen

CRISPR‐Cas9FadRSaccharomyces cerevisiaechromosomal integrationlarge DNA fragments

Substanzen

DNA, Fungal

Autor:innen und Institutionen

  • Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • China National Research Institute of Food and Fermentation Industries, Beijing, China.

Förderung

  • Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project
  • Key-Area Research and Development Program of Guangdong Province
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Xu, S., Meng, J., Zhang, Q., Tong, B., Liu, Z., Fu, J., & Shi, S. (2024). CILF: CRISPR/Cas9 based integration of large DNA fragments in Saccharomyces cerevisiae. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28830

Vancouver

Xu S, Meng J, Zhang Q, Tong B, Liu Z, Fu J, et al. CILF: CRISPR/Cas9 based integration of large DNA fragments in Saccharomyces cerevisiae. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28830

BibTeX
@article{Xu2024,
  author = {Xu, Shijie and Meng, Jie and Zhang, Qi and Tong, Baisong and Liu, Zihe and Fu, Jinyu and Shi, Shuobo},
  title = {CILF: CRISPR/Cas9 based integration of large DNA fragments in Saccharomyces cerevisiae},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  doi = {10.1002/bit.28830}
}
Kostenlos starten →